UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Nature communications, 2021-01, Vol.12 (1), p.352-352, Article 352

2021

Volltextzugriff (PDF)

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

Nature communications, 2020-01, Vol.11 (1), p.524-524, Article 524

2020

Volltextzugriff (PDF)

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma

PloS one, 2014-04, Vol.9 (4), p.e94281-e94281

2014

Volltextzugriff (PDF)

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

PloS one, 2019-01, Vol.14 (1), p.e0210608

2019

Volltextzugriff (PDF)

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

PloS one, 2011-02, Vol.6 (2), p.e16812-e16812

2011

Volltextzugriff (PDF)

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2773-2779

2009

Volltextzugriff (PDF)

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Clinical cancer research, 2007-04, Vol.13 (7), p.2158-2167

2007

Volltextzugriff (PDF)

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002203

2021

Volltextzugriff (PDF)

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma

PloS one, 2012-02, Vol.7 (2), p.e31046-e31046

2012

Volltextzugriff (PDF)

Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

SLAS discovery, 2024-03, Vol.29 (2), p.100147-100147, Article 100147

2024

Volltextzugriff (PDF)

Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17603-17608

2012

Volltextzugriff (PDF)

Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice

PloS one, 2013-03, Vol.8 (3), p.e59082

2013

Volltextzugriff (PDF)

Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells

PloS one, 2013-08, Vol.8 (8), p.e73267

2013

Volltextzugriff (PDF)

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations

Journal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.142-14, Article 142

2019

Volltextzugriff (PDF)

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Cancers, 2023-09, Vol.15 (18), p.4619

2023

Volltextzugriff (PDF)

Recurrent Glioblastoma Treated with Recombinant Poliovirus

The New England journal of medicine, 2018-07, Vol.379 (2), p.150-161

2018

Volltextzugriff (PDF)

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

Journal for immunotherapy of cancer, 2023-04, Vol.11 (4), p.e006463

2023

Volltextzugriff (PDF)

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Clinical cancer research, 2018-09, Vol.24 (17), p.4175-4186

2018

Volltextzugriff (PDF)

Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e005052

2022

Volltextzugriff (PDF)

A novel method for volumetric MRI response assessment of enhancing brain tumors

PloS one, 2011-01, Vol.6 (1), p.e16031-e16031

2011

Volltextzugriff (PDF)

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Molecular cancer therapeutics, 2005-01, Vol.4 (1), p.101-112

2005

Volltextzugriff (PDF)

Immunotoxin Therapy for Lung Cancer

Chinese medical journal, 2017-03, Vol.130 (5), p.607-612

2017

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor VIII Peptide Vaccination Is Efficacious against Established Intracerebral Tumors

Clinical cancer research, 2003-09, Vol.9 (11), p.4247-4254

2003

Volltextzugriff (PDF)

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Nature (London), 2015-03, Vol.519 (7543), p.366-369

2015

Volltextzugriff (PDF)

SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility

Molecular cancer therapeutics, 2004-06, Vol.3 (6), p.737-745

2004

Volltextzugriff (PDF)

1 – 25 von 474

Suche als RSS-Feed

Aktive Filter

KollektionAmerican Association for the Advancement of Science

Zeitschrift / SerieCancer Research

SpracheJapanisch

ThemaTumors Of The Nervous System. Phacomatoses

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(448)
Mit Volltextzugriff
(425)

Publikationsform

Artikel
(471)
Buchkapitel
(3)

Sprache

Englisch
(474)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma

Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways

Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice

Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

A novel method for volumetric MRI response assessment of enhancing brain tumors

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Immunotoxin Therapy for Lung Cancer

Epidermal Growth Factor Receptor VIII Peptide Vaccination Is Efficacious against Established Intracerebral Tumors

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility

Aktive Filter

Suchergebnisse filtern